February 21, 2019 POMPANO BEACH, Fla.–(BUSINESS WIRE)–Stimwave Technologies Incorporated issued a statement today in response to a complaint made by Nevro Corporation in Federal Court Delaware District last week alleging Stimwave is infringing Nevro’s patents covering inventions relating to that company’s neurostimulation technology. Stimwave maintains that the claims in the lawsuit are completely baseless, unfounded …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone